CDKN2A and neoplasm: However, these events followed characteristic sequences, often starting with EGFR/7p (Amp) and CDKN2A/9p (Del), then proceeding to TP53/17p (Del) and STK11/19p (Del), and culminating with the clinical detection of the tumor.